What are the differences between Ativan (lorazepam), Diazepam, and Klonopin (clonazepam) in terms of dosage and indications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparison of Ativan (Lorazepam), Diazepam, and Klonopin (Clonazepam)

Lorazepam, diazepam, and clonazepam have distinct pharmacokinetic profiles that make each more suitable for specific clinical scenarios, with lorazepam being preferred for acute anxiety and insomnia due to its intermediate action, diazepam for muscle spasms due to its longer duration, and clonazepam for seizure disorders and panic disorder due to its longer half-life and sustained action.

Key Differences in Pharmacokinetics

Lorazepam (Ativan)

  • Onset of action: 1-2 minutes IV; 15-30 minutes oral
  • Duration: Intermediate-acting (15-80 minutes IV; 12-24 hours oral)
  • Half-life: 10-20 hours
  • Dosage range:
    • Anxiety: 2-3 mg/day in divided doses (1-10 mg/day range) 1
    • Insomnia: 2-4 mg at bedtime 1
    • Status epilepticus: 0.05-0.1 mg/kg IV/IM 2
    • Elderly/debilitated: Initial 1-2 mg/day in divided doses 1

Diazepam

  • Onset of action: 1-5 minutes IV; 30-60 minutes oral
  • Duration: Long-acting (up to 24-48 hours due to active metabolites)
  • Half-life: 20-100 hours (including active metabolites)
  • Dosage range:
    • Anxiety: Initial 5-10 mg IV over 1 minute 2
    • Muscle spasms: Adjunct therapy 3
    • Alcohol withdrawal: Symptom relief for agitation, tremor 3
    • Convulsive disorders: Adjunctive therapy 3

Clonazepam (Klonopin)

  • Onset of action: 20-60 minutes oral
  • Duration: Long-acting (18-50 hours)
  • Half-life: 30-40 hours
  • Dosage range:
    • Seizure disorders: Initial ≤1.5 mg/day in 3 divided doses (max 20 mg/day) 4
    • Panic disorder: Initial 0.25 mg twice daily, target 1 mg/day (max 4 mg/day) 4
    • Pediatric seizures: 0.01-0.03 mg/kg/day initially 4
    • Elderly: Lower starting doses recommended 4

Clinical Indications

Lorazepam (Ativan)

  • Primary indications:
    • Acute anxiety
    • Short-term insomnia
    • Status epilepticus
    • Pre-procedure sedation
    • Alcohol withdrawal

Diazepam

  • Primary indications:
    • Anxiety disorders
    • Muscle spasms
    • Alcohol withdrawal
    • Adjunctive therapy for seizures
    • Acute stress reactions 5

Clonazepam (Klonopin)

  • Primary indications:
    • Seizure disorders (especially absence and myoclonic seizures)
    • Panic disorder
    • Long-term anxiety management
    • Certain movement disorders

Clinical Decision Algorithm

When to choose Lorazepam:

  • For acute anxiety requiring rapid but not immediate relief
  • For insomnia when intermediate duration is desired
  • For elderly patients (fewer active metabolites)
  • For patients with hepatic impairment
  • For status epilepticus requiring IV administration

When to choose Diazepam:

  • For muscle spasms
  • For alcohol withdrawal
  • When longer duration of action is needed
  • For episodic anxiety with intermittent dosing 5
  • When oral or IV administration options are needed

When to choose Clonazepam:

  • For seizure disorders requiring long-term management
  • For panic disorder (specifically indicated at lower doses) 4
  • When once or twice daily dosing is preferred for compliance
  • For patients who develop tolerance to shorter-acting benzodiazepines

Important Considerations and Cautions

  • All benzodiazepines:

    • Risk of tolerance, dependence, and withdrawal with prolonged use
    • Respiratory depression, especially when combined with other CNS depressants
    • Increased risk of falls and cognitive impairment in elderly
    • Paradoxical reactions in approximately 10% of patients 2
    • Should be tapered gradually when discontinuing
  • Specific cautions:

    • Lorazepam: May cause more pronounced amnesia
    • Diazepam: More likely to cause sedation due to active metabolites
    • Clonazepam: May require more careful monitoring for depression

Comparative Efficacy

  • In status epilepticus, clonazepam has shown better clinical symptom control compared to lorazepam in some studies 6
  • Lorazepam is frequently underdosed in clinical practice 6
  • For alcohol abstinence maintenance, benzodiazepines are not first-line therapy 2

Remember that benzodiazepines should generally be prescribed for short-term use (ideally ≤4 weeks) to minimize risks of dependence and tolerance 5. For long-term anxiety management, non-benzodiazepine alternatives should be considered first.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.